These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8879736)

  • 1. More cases of paroxetine withdrawal syndrome.
    Pacheco L; Malo P; Aragues E; Etxebeste M
    Br J Psychiatry; 1996 Sep; 169(3):384. PubMed ID: 8879736
    [No Abstract]   [Full Text] [Related]  

  • 2. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 3. New dosage-reduction regime to avoid paroxetine discontinuation syndrome.
    Pacheco Yáñez L; Malo P; Etxebeste M; Aragües E; Medrano J
    Can J Psychiatry; 2003 Mar; 48(2):129-30. PubMed ID: 12655918
    [No Abstract]   [Full Text] [Related]  

  • 4. [Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
    Bryois C; Rubin C; Zbinden JD; Baumann P
    Praxis (Bern 1994); 1998 Mar; 87(10):345-8. PubMed ID: 9545842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuing paroxetine: a personal account.
    Shoenberger D
    Psychother Psychosom; 2002; 71(4):237-8. PubMed ID: 12097790
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
    Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
    Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
    [No Abstract]   [Full Text] [Related]  

  • 7. Paroxetine and irritable bowel syndrome.
    Kirsch MA; Louie AK
    Am J Psychiatry; 2000 Sep; 157(9):1523-4. PubMed ID: 10964877
    [No Abstract]   [Full Text] [Related]  

  • 8. Paroxetine-induced anorexia in a patient with bulimia nervosa.
    Sagduyu K
    J Clin Psychiatry; 1997 May; 58(5):220-1. PubMed ID: 9184619
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal after discontinuation of paroxetine.
    Arya DK
    Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
    [No Abstract]   [Full Text] [Related]  

  • 12. Discontinuation symptoms and SSRIs.
    Pollock BG
    J Clin Psychiatry; 1998 Oct; 59(10):535-7. PubMed ID: 9818635
    [No Abstract]   [Full Text] [Related]  

  • 13. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Vergouwen AC; Kuipers T
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1794-5; author reply 1795-6. PubMed ID: 10494332
    [No Abstract]   [Full Text] [Related]  

  • 15. Paroxetine-induced somnambulism.
    Kawashima T; Yamada S
    J Clin Psychiatry; 2003 Apr; 64(4):483. PubMed ID: 12716257
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitor. Discontinuation syndrome.
    Finfgeld DL
    J Psychosoc Nurs Ment Health Serv; 2002 Dec; 40(12):14-8. PubMed ID: 12491870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lhermitte's sign in paroxetine withdrawal.
    Reeves RR; Pinkofsky HB
    J Clin Psychopharmacol; 1996 Oct; 16(5):411-2. PubMed ID: 8889917
    [No Abstract]   [Full Text] [Related]  

  • 18. [The serotonin syndrome].
    Kozian R
    Psychiatr Prax; 2005 Oct; 32(7):367-9. PubMed ID: 16220422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine and serotonin toxicity.
    Isbister GK; Downes F; Whyte IM
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):241-2. PubMed ID: 12667176
    [No Abstract]   [Full Text] [Related]  

  • 20. Sexual dysfunction associated with serotonin specific reuptake inhibitors.
    Herrán A; Palacios-Araus L; Vázquez-Barquero JL; Díez-Manrique JF
    J Clin Psychopharmacol; 1997 Feb; 17(1):67-8. PubMed ID: 9004071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.